Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Quest Diagnostics Inc. (DGX) Insider Trading Activity
Healthcare • Diagnostics & Research • 50,000 employees
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Total Value
-$387,616.53
Total Shares
67,929
Average Trade Value
-$5,617.63
Most Active Insider
Davis J. E.
Total Activity: $17,563,808
Largest Single Transaction
$10,757,460
by Davis J. E. on Mar 4, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Evp, Regional Businesses
Officer
|
Mar 4, 2025 | 10,380 | $1,803,421 | 78,448 (+13.2%) | Grant | |
|
SVP for Diagnostic Services
Officer
|
Mar 4, 2025 | 5,674 | $985,801 | 23,430 (+24.2%) | Grant | |
|
CEO and President
Director, Officer
|
Mar 4, 2025 | 31,656 | $5,499,913 | 166,814 (-19.0%) | Payment of Exercise Price | |
|
Evp, Regional Businesses
Officer
|
Mar 4, 2025 | 5,010 | $870,437 | 73,438 (-6.8%) | Payment of Exercise Price | |
|
CEO and President
Director, Officer
|
Mar 4, 2025 | 61,917 | $10,757,460 | 198,470 (+31.2%) | Grant | |
|
Executive Vice President CFO
Officer
|
Mar 4, 2025 | 7,684 | $1,335,018 | 26,377 (-29.1%) | Payment of Exercise Price | |
|
Svp, Corp. Controller Cao
Officer
|
Mar 4, 2025 | 867 | $150,633 | 34,365 (-2.5%) | Payment of Exercise Price | |
|
Svp, Corp. Controller Cao
Officer
|
Mar 4, 2025 | 1,711 | $297,269 | 35,232 (+4.9%) | Grant | |
|
Svp, Clinical Solutions
Officer
|
Mar 4, 2025 | 1,879 | $326,457 | 13,119 (-14.3%) | Payment of Exercise Price | |
|
SVP for Diagnostic Services
Officer
|
Mar 4, 2025 | 2,280 | $396,127 | 21,150 (-10.8%) | Payment of Exercise Price | |
|
SVP Chief Commercial Officer
Officer
|
Mar 4, 2025 | 5,317 | $923,776 | 11,300 (+47.1%) | Grant | |
|
Svp, Clinical Solutions
Officer
|
Mar 4, 2025 | 4,434 | $770,363 | 14,998 (+29.6%) | Grant | |
|
SVP General Counsel
Officer
|
Mar 4, 2025 | 3,906 | $678,628 | 42,760 (-9.1%) | Payment of Exercise Price | |
|
SVP Chief Commercial Officer
Officer
|
Mar 4, 2025 | 1,823 | $316,728 | 9,477 (-19.2%) | Payment of Exercise Price | |
|
Executive Vice President CFO
Officer
|
Mar 4, 2025 | 13,884 | $2,412,206 | 34,061 (+40.8%) | Grant | |
|
Evp, Regional Businesses
Officer
|
Mar 4, 2025 | 716 | $125,866 | 68,068 (-1.1%) | Sale | |
|
SVP General Counsel
Officer
|
Mar 4, 2025 | 8,549 | $1,485,303 | 46,666 (+18.3%) | Grant | |
|
SVP General Counsel
Officer
|
Mar 4, 2025 | 592 | $104,068 | 38,117 (-1.6%) | Sale | |
|
Svp, Clinical Solutions
Officer
|
Mar 3, 2025 | 992 | $172,350 | 10,564 (-9.4%) | Payment of Exercise Price | |
|
Svp, Corp. Controller Cao
Officer
|
Mar 3, 2025 | 1,692 | $293,968 | 33,521 (-5.0%) | Payment of Exercise Price | |
|
SVP for Diagnostic Services
Officer
|
Mar 3, 2025 | 106 | $18,416 | 17,756 (-0.6%) | Payment of Exercise Price | |
|
SVP General Counsel
Officer
|
Mar 3, 2025 | 322 | $55,944 | 38,709 (-0.8%) | Payment of Exercise Price | |
|
Evp, Regional Businesses
Officer
|
Mar 3, 2025 | 394 | $68,454 | 68,784 (-0.6%) | Payment of Exercise Price | |
|
CEO and President
Director, Officer
|
Mar 3, 2025 | 1,662 | $288,756 | 136,553 (-1.2%) | Payment of Exercise Price | |
|
SVP General Counsel
Officer
|
Feb 27, 2025 | 528 | $91,138 | 39,031 (-1.4%) | Sale | |
|
Evp, Regional Businesses
Officer
|
Feb 27, 2025 | 824 | $142,231 | 69,178 (-1.2%) | Sale | |
|
SVP for Diagnostic Services
Officer
|
Feb 26, 2025 | 229 | $39,331 | 17,853 (-1.3%) | Payment of Exercise Price | |
|
Evp, Regional Businesses
Officer
|
Feb 26, 2025 | 455 | $78,146 | 70,002 (-0.6%) | Payment of Exercise Price | |
|
Svp, Clinical Solutions
Officer
|
Feb 26, 2025 | 233 | $40,018 | 11,546 (-2.0%) | Payment of Exercise Price | |
|
Svp, Corp. Controller Cao
Officer
|
Feb 26, 2025 | 88 | $15,114 | 35,212 (-0.2%) | Payment of Exercise Price | |
|
SVP General Counsel
Officer
|
Feb 26, 2025 | 286 | $49,121 | 39,559 (-0.7%) | Payment of Exercise Price | |
|
Executive Vice President CFO
Officer
|
Feb 26, 2025 | 869 | $149,251 | 20,177 (-4.3%) | Payment of Exercise Price | |
|
SVP Chief Commercial Officer
Officer
|
Feb 26, 2025 | 214 | $36,755 | 5,983 (-3.6%) | Payment of Exercise Price | |
|
CEO and President
Director, Officer
|
Feb 26, 2025 | 2,966 | $509,411 | 138,215 (-2.1%) | Payment of Exercise Price | |
|
Evp, Regional Businesses
Officer
|
Feb 20, 2025 | 899 | $153,720 | 70,457 (-1.3%) | Sale | |
|
SVP General Counsel
Officer
|
Feb 20, 2025 | 604 | $103,278 | 39,845 (-1.5%) | Sale | |
|
Executive Vice President CFO
Officer
|
Feb 19, 2025 | 1,031 | $174,971 | 21,046 (-4.9%) | Payment of Exercise Price | |
|
SVP General Counsel
Officer
|
Feb 19, 2025 | 374 | $63,472 | 40,449 (-0.9%) | Payment of Exercise Price | |
|
Svp, Clinical Solutions
Officer
|
Feb 19, 2025 | 287 | $48,707 | 11,779 (-2.4%) | Payment of Exercise Price | |
|
Evp, Regional Businesses
Officer
|
Feb 19, 2025 | 535 | $90,795 | 71,356 (-0.7%) | Sale | |
|
SVP for Diagnostic Services
Officer
|
Feb 19, 2025 | 320 | $54,307 | 18,082 (-1.8%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Feb 19, 2025 | 99 | $16,801 | 35,300 (-0.3%) | Payment of Exercise Price | |
|
SVP Chief Commercial Officer
Officer
|
Feb 19, 2025 | 242 | $41,070 | 6,197 (-3.9%) | Payment of Exercise Price | |
|
CEO and President
Director, Officer
|
Feb 19, 2025 | 2,936 | $498,269 | 141,181 (-2.1%) | Payment of Exercise Price | |
|
Svp, Clinical Solutions
Officer
|
Feb 12, 2025 | 2,269 | $10,000 | 12,066 (+18.8%) | Grant | |
|
CEO and President
Director, Officer
|
Feb 12, 2025 | 18,149 | $10,000 | 144,117 (+12.6%) | Grant | |
|
SVP for Diagnostic Services
Officer
|
Feb 12, 2025 | 2,042 | $10,000 | 18,402 (+11.1%) | Grant | |
|
SVP General Counsel
Officer
|
Feb 12, 2025 | 2,345 | $10,000 | 40,823 (+5.7%) | Grant | |
|
Svp, Corp. Controller Cao
Officer
|
Feb 12, 2025 | 454 | $10,000 | 35,399 (+1.3%) | Grant | |
|
Executive Vice President CFO
Officer
|
Feb 12, 2025 | 4,538 | $10,000 | 22,077 (+20.6%) | Grant | |
|
Evp, Regional Businesses
Officer
|
Feb 12, 2025 | 3,479 | $10,000 | 71,891 (+4.8%) | Grant | |
|
SVP Chief Commercial Officer
Officer
|
Feb 12, 2025 | 1,815 | $10,000 | 6,439 (+28.2%) | Grant | |
|
Director
|
Feb 5, 2025 | 1,250 | $205,710 | 16,867 (-7.4%) | Sale | |
|
SVP Chief Commercial Officer
Officer
|
Feb 5, 2025 | 403 | $66,214 | 4,624 (-8.7%) | Sale | |
|
SVP General Counsel
Officer
|
Nov 29, 2024 | 3,009 | $488,237 | 70,615 (-4.3%) | Sale | |
|
SVP General Counsel
Officer
|
Nov 29, 2024 | 32,137 | $5,243,065 | 38,478 (-83.5%) | Sale | |
|
SVP General Counsel
Officer
|
Nov 29, 2024 | 35,146 | $3,044,698 | 73,624 (+47.7%) | Exercise/Conversion | |
|
Evp, Regional Businesses
Officer
|
Nov 27, 2024 | 4,803 | $778,775 | 96,712 (-5.0%) | Sale | |
|
Evp, Regional Businesses
Officer
|
Nov 27, 2024 | 28,300 | $4,616,709 | 68,412 (-41.4%) | Sale | |
|
Evp, Regional Businesses
Officer
|
Nov 27, 2024 | 33,103 | $3,428,478 | 101,515 (+32.6%) | Exercise/Conversion | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 8,635 | $614,553 | 43,576 (+19.8%) | Exercise/Conversion | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 4,135 | $639,833 | 45,061 (-9.2%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 2,600 | $397,050 | 42,461 (-6.1%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 2,100 | $320,676 | 51,596 (-4.1%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 2,400 | $369,559 | 49,196 (-4.9%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 5,189 | $802,958 | 34,941 (-14.9%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 2,331 | $359,046 | 40,130 (-5.8%) | Sale | |
|
Svp, Corp. Controller Cao
Officer
|
Nov 6, 2024 | 10,120 | $673,081 | 53,696 (+18.8%) | Exercise/Conversion | |
|
Svp, Clinical Solutions
Officer
|
Oct 28, 2024 | 1,775 | $278,525 | 9,734 (-18.2%) | Sale |